There is no evidence that post-mortem samples were taken from a premature baby after his death, a hospital boss has said.
There is no evidence that post-mortem samples were taken from a premature baby after his death, a hospital boss has said.
20h
TipRanks on MSNBonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug TrialBonus Biogroup has received FDA approval for an IND application to conduct a Phase III clinical trial of a drug designed to treat acute respiratory distress syndrome (ARDS), especially in severe COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results